Rhenman & Partners Asset Management AB Lowers Holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)
Rhenman & Partners Asset Management AB reduced its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 53.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 100,400 shares of the company’s stock after selling 114,600 […]
More Stories
Veeco Instruments (NASDAQ:VECO) Downgraded by StockNews.com
StockNews.com cut shares of Veeco Instruments (NASDAQ:VECO – Free Report) from a hold rating to a sell rating in a...
XOS (NASDAQ:XOS) Raised to “Strong-Buy” at Northland Capmk
Northland Capmk upgraded shares of XOS (NASDAQ:XOS – Free Report) to a strong-buy rating in a report issued on Wednesday,...
Verona Pharma (NASDAQ:VRNA) Now Covered by Wells Fargo & Company
Equities research analysts at Wells Fargo & Company began coverage on shares of Verona Pharma (NASDAQ:VRNA – Get Free Report)...
Analysts Set BP p.l.c. (LON:BP) Target Price at GBX 636.67
Shares of BP p.l.c. (LON:BP – Get Free Report) have received a consensus recommendation of “Hold” from the eight brokerages...
Contrasting ExlService (NASDAQ:EXLS) & MOGU (NYSE:MOGU)
MOGU (NYSE:MOGU – Get Free Report) and ExlService (NASDAQ:EXLS – Get Free Report) are both retail/wholesale companies, but which is...
Comparing Energy Fuels (NYSE:UUUU) & Intrepid Potash (NYSE:IPI)
Intrepid Potash (NYSE:IPI – Get Free Report) and Energy Fuels (NYSE:UUUU – Get Free Report) are both small-cap basic materials...